{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T11:13:37Z","timestamp":1784805217652,"version":"3.55.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T00:00:00Z","timestamp":1631145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T00:00:00Z","timestamp":1631145600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31601184"],"award-info":[{"award-number":["31601184"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970537"],"award-info":[{"award-number":["81970537"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the National Key Research and Development Program of China","award":["2017YFA0106100"],"award-info":[{"award-number":["2017YFA0106100"]}]},{"name":"Guangdong Basic and Applied Basic Research Foundation","award":["2020A1515011385"],"award-info":[{"award-number":["2020A1515011385"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Fulminant hepatitis is a severe life-threatening clinical condition with rapid progressive loss of liver function. It is characterized by massive activation and infiltration of immune cells into the liver and\u00a0disturbance of inflammatory cytokine production. Mesenchymal stem cells (MSCs) showed potent immunomodulatory properties. Transplantation of MSCs is suggested as a promising therapeutic approach for a host of inflammatory conditions.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In the current study, a well-established concanavalin A (Con A)-induced fulminant hepatitis mouse model was used to investigate the effects of transplanting human umbilical cord Wharton's jelly-derived MSCs (hWJ-MSCs) on fulminant hepatitis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We showed that hWJ-MSCs effectively alleviate fulminant hepatitis in mouse models, primarily through inhibiting T cell immunity. RNA sequencing of liver tissues and human T cells co-cultured with hWJ-MSCs showed that NF-\u03baB signaling and glycolysis are two main pathways mediating the protective role of hWJ-MSCs on both Con A-induced hepatitis in vivo and T cell activation in vitro.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>In summary, our data confirmed the potent therapeutic role of MSCs-derived from Wharton's jelly of human umbilical cord on Con A-induced fulminant hepatitis, and uncovered new mechanisms that glycolysis metabolic shift mediates suppression of T cell immunity by hWJ-MSCs.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13287-021-02560-x","type":"journal-article","created":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T09:02:47Z","timestamp":1631178167000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Human Wharton's jelly-derived mesenchymal stem cells alleviate concanavalin A-induced fulminant hepatitis by repressing NF-\u03baB signaling and glycolysis"],"prefix":"10.1186","volume":"12","author":[{"given":"Lijie","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinmei","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuowei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaxin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqi","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajie","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5653-291X","authenticated-orcid":false,"given":"Yan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,9]]},"reference":[{"issue":"Suppl 2","key":"2560_CR1","doi-asserted-by":"publisher","first-page":"S67","DOI":"10.1002\/lt.21612","volume":"14","author":"P Ichai","year":"2008","unstructured":"Ichai P, Samuel D. Etiology and prognosis of fulminant hepatitis in adults. Liver Transpl. 2008;14(Suppl 2):S67-79.","journal-title":"Liver Transpl"},{"issue":"5","key":"2560_CR2","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1634\/stemcells.2005-0342","volume":"24","author":"S Kern","year":"2006","unstructured":"Kern S, Eichler H, Stoeve J, Kluter H, Bieback K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells. 2006;24(5):1294\u2013301.","journal-title":"Stem Cells"},{"issue":"8","key":"2560_CR3","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1182\/blood.V98.8.2396","volume":"98","author":"C Campagnoli","year":"2001","unstructured":"Campagnoli C, Roberts IA, Kumar S, Bennett PR, Bellantuono I, Fisk NM. Identification of mesenchymal stem\/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood. 2001;98(8):2396\u2013402.","journal-title":"Blood"},{"issue":"1","key":"2560_CR4","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1186\/s13287-021-02511-6","volume":"12","author":"L Chen","year":"2021","unstructured":"Chen L, Qu J, Mei Q, Chen X, Fang Y, Chen L, et al. Small extracellular vesicles from menstrual blood-derived mesenchymal stem cells (MenSCs) as a novel therapeutic impetus in regenerative medicine. Stem Cell Res Ther. 2021;12(1):433.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"2560_CR5","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13287-019-1136-x","volume":"10","author":"L Ling","year":"2019","unstructured":"Ling L, Feng X, Wei T, Wang Y, Wang Y, Wang Z, et al. Human amnion-derived mesenchymal stem cell (hAD-MSC) transplantation improves ovarian function in rats with premature ovarian insufficiency (POI) at least partly through a paracrine mechanism. Stem Cell Res Ther. 2019;10(1):46.","journal-title":"Stem Cell Res Ther"},{"key":"2560_CR6","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3389\/fimmu.2013.00188","volume":"4","author":"AK Antony","year":"2013","unstructured":"Antony AK, Rodby K, Tobin MK, O\u2019Connor MI, Pearl RK, DiPietro LA, et al. Composite tissue allotransplantation and dysregulation in tissue repair and regeneration: a role for mesenchymal stem cells. Front Immunol. 2013;4:188.","journal-title":"Front Immunol"},{"issue":"3","key":"2560_CR7","doi-asserted-by":"publisher","first-page":"73","DOI":"10.4252\/wjsc.v8.i3.73","volume":"8","author":"A De Becker","year":"2016","unstructured":"De Becker A, Riet IV. Homing and migration of mesenchymal stromal cells: how to improve the efficacy of cell therapy? World J Stem Cells. 2016;8(3):73\u201387.","journal-title":"World J Stem Cells"},{"key":"2560_CR8","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1146\/annurev-pathol-011110-130230","volume":"6","author":"NG Singer","year":"2011","unstructured":"Singer NG, Caplan AI. Mesenchymal stem cells: mechanisms of inflammation. Annu Rev Pathol. 2011;6:457\u201378.","journal-title":"Annu Rev Pathol"},{"issue":"3","key":"2560_CR9","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/leu.2014.225","volume":"29","author":"Y Peng","year":"2015","unstructured":"Peng Y, Chen X, Liu Q, Zhang X, Huang K, Liu L, et al. Mesenchymal stromal cells infusions improve refractory chronic graft versus host disease through an increase of CD5+ regulatory B cells producing interleukin 10. Leukemia. 2015;29(3):636\u201346.","journal-title":"Leukemia"},{"key":"2560_CR10","doi-asserted-by":"publisher","first-page":"3562753","DOI":"10.1155\/2020\/3562753","volume":"2020","author":"M Ghoryani","year":"2020","unstructured":"Ghoryani M, Shariati-Sarabi Z, Tavakkol-Afshari J, Mohammadi M. The sufficient immunoregulatory effect of autologous bone marrow-derived mesenchymal stem cell transplantation on regulatory T cells in patients with refractory rheumatoid arthritis. J Immunol Res. 2020;2020:3562753.","journal-title":"J Immunol Res"},{"issue":"5","key":"2560_CR11","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1093\/ibd\/izz215","volume":"26","author":"AL Lightner","year":"2020","unstructured":"Lightner AL, Dozois EJ, Dietz AB, Fletcher JG, Friton J, Butler G, et al. Matrix-delivered autologous mesenchymal stem cell therapy for refractory rectovaginal Crohn\u2019s fistulas. Inflamm Bowel Dis. 2020;26(5):670\u20137.","journal-title":"Inflamm Bowel Dis"},{"key":"2560_CR12","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3389\/fimmu.2020.00054","volume":"11","author":"M Bulati","year":"2020","unstructured":"Bulati M, Miceli V, Gallo A, Amico G, Carcione C, Pampalone M, et al. The immunomodulatory properties of the human amnion-derived mesenchymal stromal\/stem cells are induced by INF-gamma produced by activated lymphomonocytes and are mediated by cell-to-cell contact and soluble factors. Front Immunol. 2020;11:54.","journal-title":"Front Immunol"},{"issue":"4","key":"2560_CR13","doi-asserted-by":"publisher","first-page":"344","DOI":"10.2174\/1574888X14666181205115452","volume":"14","author":"A Poggi","year":"2019","unstructured":"Poggi A, Zocchi MR. Immunomodulatory properties of mesenchymal stromal cells: still unresolved \u201cYin and Yang.\u201d Curr Stem Cell Res Ther. 2019;14(4):344\u201350.","journal-title":"Curr Stem Cell Res Ther"},{"issue":"8","key":"2560_CR14","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41581-018-0023-5","volume":"14","author":"Y Shi","year":"2018","unstructured":"Shi Y, Wang Y, Li Q, Liu K, Hou J, Shao C, et al. Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases. Nat Rev Nephrol. 2018;14(8):493\u2013507.","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"2560_CR15","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.stem.2007.11.014","volume":"2","author":"G Ren","year":"2008","unstructured":"Ren G, Zhang L, Zhao X, Xu G, Zhang Y, Roberts AI, et al. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell. 2008;2(2):141\u201350.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"2560_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1600-0897.2011.01069.x","volume":"67","author":"E Soleymaninejadian","year":"2012","unstructured":"Soleymaninejadian E, Pramanik K, Samadian E. Immunomodulatory properties of mesenchymal stem cells: cytokines and factors. Am J Reprod Immunol. 2012;67(1):1\u20138.","journal-title":"Am J Reprod Immunol"},{"issue":"1","key":"2560_CR17","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/hep.29189","volume":"66","author":"BL Lin","year":"2017","unstructured":"Lin BL, Chen JF, Qiu WH, Wang KW, Xie DY, Chen XY, et al. Allogeneic bone marrow-derived mesenchymal stromal cells for hepatitis B virus-related acute-on-chronic liver failure: a randomized controlled trial. Hepatology. 2017;66(1):209\u201319.","journal-title":"Hepatology"},{"issue":"10","key":"2560_CR18","doi-asserted-by":"publisher","first-page":"725","DOI":"10.5966\/sctm.2012-0034","volume":"1","author":"M Shi","year":"2012","unstructured":"Shi M, Zhang Z, Xu R, Lin H, Fu J, Zou Z, et al. Human mesenchymal stem cell transfusion is safe and improves liver function in acute-on-chronic liver failure patients. Stem Cells Transl Med. 2012;1(10):725\u201331.","journal-title":"Stem Cells Transl Med"},{"key":"2560_CR19","doi-asserted-by":"publisher","first-page":"6494","DOI":"10.1038\/srep06494","volume":"4","author":"K Sun","year":"2014","unstructured":"Sun K, Xie X, Xie J, Jiao S, Chen X, Zhao X, et al. Cell-based therapy for acute and chronic liver failures: distinct diseases, different choices. Sci Rep. 2014;4:6494.","journal-title":"Sci Rep"},{"issue":"1","key":"2560_CR20","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1172\/JCI115836","volume":"90","author":"G Tiegs","year":"1992","unstructured":"Tiegs G, Hentschel J, Wendel A. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J Clin Investig. 1992;90(1):196\u2013203.","journal-title":"J Clin Investig"},{"issue":"2","key":"2560_CR21","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1053\/gast.1996.v111.pm8690213","volume":"111","author":"S Kusters","year":"1996","unstructured":"Kusters S, Gantner F, Kunstle G, Tiegs G. Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A. Gastroenterology. 1996;111(2):462\u201371.","journal-title":"Gastroenterology"},{"issue":"1 Suppl","key":"2560_CR22","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1177\/0023677215572841","volume":"49","author":"F Heymann","year":"2015","unstructured":"Heymann F, Hamesch K, Weiskirchen R, Tacke F. The concanavalin A model of acute hepatitis in mice. Lab Anim. 2015;49(1 Suppl):12\u201320.","journal-title":"Lab Anim"},{"issue":"3","key":"2560_CR23","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1159\/000489074","volume":"46","author":"T Ye","year":"2018","unstructured":"Ye T, Wang T, Yang X, Fan X, Wen M, Shen Y, et al. Comparison of concanavalin A-induced murine autoimmune hepatitis models. Cell Physiol Biochem. 2018;46(3):1241\u201351.","journal-title":"Cell Physiol Biochem"},{"key":"2560_CR24","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12575-019-0112-2","volume":"21","author":"L Zhou","year":"2019","unstructured":"Zhou L, Liu S, Wang Z, Yao J, Cao W, Chen S, et al. Bone marrow-derived mesenchymal stem cells modified with Akt1 ameliorates acute liver GVHD. Biol Proced Online. 2019;21:24.","journal-title":"Biol Proced Online"},{"key":"2560_CR25","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s41232-016-0030-5","volume":"36","author":"R Tamura","year":"2016","unstructured":"Tamura R, Uemoto S, Tabata Y. Immunosuppressive effect of mesenchymal stem cell-derived exosomes on a concanavalin A-induced liver injury model. Inflamm Regen. 2016;36:26.","journal-title":"Inflamm Regen"},{"issue":"3","key":"2560_CR26","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s00441-012-1524-3","volume":"351","author":"X Zhu","year":"2013","unstructured":"Zhu X, He B, Zhou X, Ren J. Effects of transplanted bone-marrow-derived mesenchymal stem cells in animal models of acute hepatitis. Cell Tissue Res. 2013;351(3):477\u201386.","journal-title":"Cell Tissue Res"},{"issue":"5","key":"2560_CR27","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41419-018-0532-y","volume":"9","author":"Y Gu","year":"2018","unstructured":"Gu Y, Ding X, Huang J, Xue M, Zhang J, Wang Q, et al. The deubiquitinating enzyme UCHL1 negatively regulates the immunosuppressive capacity and survival of multipotent mesenchymal stromal cells. Cell Death Dis. 2018;9(5):459.","journal-title":"Cell Death Dis"},{"issue":"11","key":"2560_CR28","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1038\/cdd.2014.85","volume":"21","author":"X Han","year":"2014","unstructured":"Han X, Yang Q, Lin L, Xu C, Zheng C, Chen X, et al. Interleukin-17 enhances immunosuppression by mesenchymal stem cells. Cell Death Differ. 2014;21(11):1758\u201368.","journal-title":"Cell Death Differ"},{"issue":"6","key":"2560_CR29","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/j.jhep.2015.07.035","volume":"63","author":"KC Lee","year":"2015","unstructured":"Lee KC, Lin HC, Huang YH, Hung SC. Allo-transplantation of mesenchymal stem cells attenuates hepatic injury through IL1Ra dependent macrophage switch in a mouse model of liver disease. J Hepatol. 2015;63(6):1405\u201312.","journal-title":"J Hepatol"},{"issue":"2","key":"2560_CR30","doi-asserted-by":"publisher","first-page":"e1173","DOI":"10.1002\/term.2452","volume":"12","author":"M Gazdic","year":"2018","unstructured":"Gazdic M, Simovic Markovic B, Vucicevic L, Nikolic T, Djonov V, Arsenijevic N, et al. Mesenchymal stem cells protect from acute liver injury by attenuating hepatotoxicity of liver natural killer T cells in an inducible nitric oxide synthase- and indoleamine 2,3-dioxygenase-dependent manner. J Tissue Eng Regen Med. 2018;12(2):e1173\u201385.","journal-title":"J Tissue Eng Regen Med"},{"issue":"1","key":"2560_CR31","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.yexcr.2014.06.007","volume":"326","author":"KH Ryu","year":"2014","unstructured":"Ryu KH, Kim SY, Kim YR, Woo SY, Sung SH, Kim HS, et al. Tonsil-derived mesenchymal stem cells alleviate concanavalin A-induced acute liver injury. Exp Cell Res. 2014;326(1):143\u201354.","journal-title":"Exp Cell Res"},{"issue":"11","key":"2560_CR32","doi-asserted-by":"publisher","first-page":"2956","DOI":"10.1002\/eji.201343531","volume":"43","author":"M Higashimoto","year":"2013","unstructured":"Higashimoto M, Sakai Y, Takamura M, Usui S, Nasti A, Yoshida K, et al. Adipose tissue derived stromal stem cell therapy in murine ConA-derived hepatitis is dependent on myeloid-lineage and CD4+ T-cell suppression. Eur J Immunol. 2013;43(11):2956\u201368.","journal-title":"Eur J Immunol"},{"issue":"1","key":"2560_CR33","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/j.1440-1746.2011.06798.x","volume":"27","author":"N Kubo","year":"2012","unstructured":"Kubo N, Narumi S, Kijima H, Mizukami H, Yagihashi S, Hakamada K, et al. Efficacy of adipose tissue-derived mesenchymal stem cells for fulminant hepatitis in mice induced by concanavalin A. J Gastroenterol Hepatol. 2012;27(1):165\u201372.","journal-title":"J Gastroenterol Hepatol"},{"issue":"12","key":"2560_CR34","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1002\/eji.201646835","volume":"47","author":"A Nasti","year":"2017","unstructured":"Nasti A, Sakai Y, Seki A, Buffa GB, Komura T, Mochida H, et al. The CD45(+) fraction in murine adipose tissue derived stromal cells harbors immune-inhibitory inflammatory cells. Eur J Immunol. 2017;47(12):2163\u201374.","journal-title":"Eur J Immunol"},{"issue":"2","key":"2560_CR35","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1089\/hum.2017.171","volume":"29","author":"W Wang","year":"2018","unstructured":"Wang W, Guo H, Li H, Yan Y, Wu C, Wang X, et al. Interleukin-35 gene-modified mesenchymal stem cells protect concanavalin A-induced fulminant hepatitis by decreasing the interferon gamma level. Hum Gene Ther. 2018;29(2):234\u201341.","journal-title":"Hum Gene Ther"},{"issue":"11","key":"2560_CR36","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1634\/stemcells.2007-1028","volume":"26","author":"ML Weiss","year":"2008","unstructured":"Weiss ML, Anderson C, Medicetty S, Seshareddy KB, Weiss RJ, VanderWerff I, et al. Immune properties of human umbilical cord Wharton\u2019s jelly-derived cells. Stem Cells. 2008;26(11):2865\u201374.","journal-title":"Stem Cells"},{"issue":"3","key":"2560_CR37","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1634\/stemcells.2005-0330","volume":"24","author":"ML Weiss","year":"2006","unstructured":"Weiss ML, Medicetty S, Bledsoe AR, Rachakatla RS, Choi M, Merchav S, et al. Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson\u2019s disease. Stem Cells. 2006;24(3):781\u201392.","journal-title":"Stem Cells"},{"issue":"4","key":"2560_CR38","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/s41556-018-0047-x","volume":"20","author":"Q Zhuang","year":"2018","unstructured":"Zhuang Q, Li W, Benda C, Huang Z, Ahmed T, Liu P, et al. NCoR\/SMRT co-repressors cooperate with c-MYC to create an epigenetic barrier to somatic cell reprogramming. Nat Cell Biol. 2018;20(4):400\u201312.","journal-title":"Nat Cell Biol"},{"issue":"43","key":"2560_CR39","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"2560_CR40","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550.","journal-title":"Genome Biol"},{"issue":"10","key":"2560_CR41","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1172\/JCI0215841","volume":"110","author":"F Hong","year":"2002","unstructured":"Hong F, Jaruga B, Kim WH, Radaeva S, El-Assal ON, Tian Z, et al. Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS. J Clin Investig. 2002;110(10):1503\u201313.","journal-title":"J Clin Investig"},{"issue":"2","key":"2560_CR42","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1002\/hep.21498","volume":"45","author":"A Erhardt","year":"2007","unstructured":"Erhardt A, Biburger M, Papadopoulos T, Tiegs G. IL-10, regulatory T cells, and Kupffer cells mediate tolerance in concanavalin A-induced liver injury in mice. Hepatology. 2007;45(2):475\u201385.","journal-title":"Hepatology"},{"issue":"5","key":"2560_CR43","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1016\/S0002-9440(10)64804-3","volume":"157","author":"J Schumann","year":"2000","unstructured":"Schumann J, Wolf D, Pahl A, Brune K, Papadopoulos T, van Rooijen N, et al. Importance of Kupffer cells for T-cell-dependent liver injury in mice. Am J Pathol. 2000;157(5):1671\u201383.","journal-title":"Am J Pathol"},{"issue":"10","key":"2560_CR44","doi-asserted-by":"publisher","first-page":"5498","DOI":"10.1073\/pnas.040566697","volume":"97","author":"K Takeda","year":"2000","unstructured":"Takeda K, Hayakawa Y, Van Kaer L, Matsuda H, Yagita H, Okumura K. Critical contribution of liver natural killer T cells to a murine model of hepatitis. Proc Natl Acad Sci U S A. 2000;97(10):5498\u2013503.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"2560_CR45","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.cell.2013.05.016","volume":"153","author":"CH Chang","year":"2013","unstructured":"Chang CH, Curtis JD, Maggi LB Jr, Faubert B, Villarino AV, O\u2019Sullivan D, et al. Posttranscriptional control of T cell effector function by aerobic glycolysis. Cell. 2013;153(6):1239\u201351.","journal-title":"Cell"},{"issue":"3","key":"2560_CR46","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.cmet.2020.07.007","volume":"32","author":"AC Codo","year":"2020","unstructured":"Codo AC, Davanzo GG, Monteiro LB, de Souza GF, Muraro SP, Virgilio-da-Silva JV, et al. Elevated glucose levels favor SARS-CoV-2 infection and monocyte response through a HIF-1alpha\/glycolysis-dependent axis. Cell Metab. 2020;32(3):437\u201346.","journal-title":"Cell Metab"},{"issue":"6204","key":"2560_CR47","doi-asserted-by":"publisher","first-page":"1250684","DOI":"10.1126\/science.1250684","volume":"345","author":"SC Cheng","year":"2014","unstructured":"Cheng SC, Quintin J, Cramer RA, Shepardson KM, Saeed S, Kumar V, et al. mTOR- and HIF-1alpha-mediated aerobic glycolysis as metabolic basis for trained immunity. Science. 2014;345(6204):1250684.","journal-title":"Science"},{"issue":"5411","key":"2560_CR48","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1126\/science.284.5411.143","volume":"284","author":"MF Pittenger","year":"1999","unstructured":"Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284(5411):143\u20137.","journal-title":"Science"},{"issue":"5","key":"2560_CR49","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/nri3209","volume":"12","author":"K Le Blanc","year":"2012","unstructured":"Le Blanc K, Mougiakakos D. Multipotent mesenchymal stromal cells and the innate immune system. Nat Rev Immunol. 2012;12(5):383\u201396.","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"2560_CR50","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/nri2395","volume":"8","author":"A Uccelli","year":"2008","unstructured":"Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol. 2008;8(9):726\u201336.","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"2560_CR51","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.stem.2018.05.004","volume":"22","author":"J Galipeau","year":"2018","unstructured":"Galipeau J, Sensebe L. Mesenchymal stromal cells: clinical challenges and therapeutic opportunities. Cell Stem Cell. 2018;22(6):824\u201333.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"2560_CR52","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1084\/jem.191.1.105","volume":"191","author":"Y Kaneko","year":"2000","unstructured":"Kaneko Y, Harada M, Kawano T, Yamashita M, Shibata Y, Gejyo F, et al. Augmentation of Valpha14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis. J Exp Med. 2000;191(1):105\u201314.","journal-title":"J Exp Med"},{"issue":"6","key":"2560_CR53","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1002\/hep.510270611","volume":"27","author":"AW Lohse","year":"1998","unstructured":"Lohse AW, Dienes HP, Meyer zum Buschenfelde KH. Suppression of murine experimental autoimmune hepatitis by T-cell vaccination or immunosuppression. Hepatology. 1998;27(6):1536\u201343.","journal-title":"Hepatology"},{"issue":"2","key":"2560_CR54","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3748\/wjg.v18.i2.119","volume":"18","author":"HX Wang","year":"2012","unstructured":"Wang HX, Liu M, Weng SY, Li JJ, Xie C, He HL, et al. Immune mechanisms of concanavalin A model of autoimmune hepatitis. World J Gastroenterol. 2012;18(2):119\u201325.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"2560_CR55","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1002\/hep.510240413","volume":"24","author":"PA Knolle","year":"1996","unstructured":"Knolle PA, Gerken G, Loser E, Dienes HP, Gantner F, Tiegs G, et al. Role of sinusoidal endothelial cells of the liver in concanavalin A-induced hepatic injury in mice. Hepatology. 1996;24(4):824\u20139.","journal-title":"Hepatology"},{"issue":"6","key":"2560_CR56","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1002\/hep.510250614","volume":"25","author":"H Louis","year":"1997","unstructured":"Louis H, Le Moine O, Peny MO, Quertinmont E, Fokan D, Goldman M, et al. Production and role of interleukin-10 in concanavalin A-induced hepatitis in mice. Hepatology. 1997;25(6):1382\u20139.","journal-title":"Hepatology"},{"issue":"11","key":"2560_CR57","doi-asserted-by":"publisher","first-page":"e2462","DOI":"10.1038\/cddis.2016.362","volume":"7","author":"A Filliol","year":"2016","unstructured":"Filliol A, Piquet-Pellorce C, Le Seyec J, Farooq M, Genet V, Lucas-Clerc C, et al. RIPK1 protects from TNF-alpha-mediated liver damage during hepatitis. Cell Death Dis. 2016;7(11):e2462.","journal-title":"Cell Death Dis"},{"key":"2560_CR58","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.freeradbiomed.2019.11.033","volume":"147","author":"P Zhang","year":"2020","unstructured":"Zhang P, Yin Y, Wang T, Li W, Li C, Zeng X, et al. Maresin 1 mitigates concanavalin A-induced acute liver injury in mice by inhibiting ROS-mediated activation of NF-kappaB signaling. Free Radic Biol Med. 2020;147:23\u201336.","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"2560_CR59","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1182\/blood-2010-12-327353","volume":"118","author":"H Choi","year":"2011","unstructured":"Choi H, Lee RH, Bazhanov N, Oh JY, Prockop DJ. Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2\/NF-kappaB signaling in resident macrophages. Blood. 2011;118(2):330\u20138.","journal-title":"Blood"},{"issue":"10","key":"2560_CR60","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1038\/mt.2010.155","volume":"18","author":"H Yagi","year":"2010","unstructured":"Yagi H, Soto-Gutierrez A, Navarro-Alvarez N, Nahmias Y, Goldwasser Y, Kitagawa Y, et al. Reactive bone marrow stromal cells attenuate systemic inflammation via sTNFR1. Mol Ther. 2010;18(10):1857\u201364.","journal-title":"Mol Ther"},{"issue":"1","key":"2560_CR61","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/mt.2011.211","volume":"20","author":"DJ Prockop","year":"2012","unstructured":"Prockop DJ, Oh JY. Mesenchymal stem\/stromal cells (MSCs): role as guardians of inflammation. Mol Ther. 2012;20(1):14\u201320.","journal-title":"Mol Ther"},{"issue":"2","key":"2560_CR62","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s00125-019-05043-0","volume":"63","author":"B Fan","year":"2020","unstructured":"Fan B, Li C, Szalad A, Wang L, Pan W, Zhang R, et al. Mesenchymal stromal cell-derived exosomes ameliorate peripheral neuropathy in a mouse model of diabetes. Diabetologia. 2020;63(2):431\u201343.","journal-title":"Diabetologia"},{"key":"2560_CR63","doi-asserted-by":"publisher","first-page":"15620","DOI":"10.1038\/ncomms15620","volume":"8","author":"SJ Lawless","year":"2017","unstructured":"Lawless SJ, Kedia-Mehta N, Walls JF, McGarrigle R, Convery O, Sinclair LV, et al. Glucose represses dendritic cell-induced T cell responses. Nat Commun. 2017;8:15620.","journal-title":"Nat Commun"},{"issue":"6","key":"2560_CR64","doi-asserted-by":"publisher","first-page":"575","DOI":"10.3390\/cells8060575","volume":"8","author":"M Kunkl","year":"2019","unstructured":"Kunkl M, Sambucci M, Ruggieri S, Amormino C, Tortorella C, Gasperini C, et al. CD28 autonomous signaling up-regulates C-Myc expression and promotes glycolysis enabling inflammatory T cell responses in multiple sclerosis. Cells. 2019;8(6):575.","journal-title":"Cells"},{"key":"2560_CR65","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.3389\/fimmu.2019.02191","volume":"10","author":"Q Li","year":"2019","unstructured":"Li Q, Yan Y, Liu J, Huang X, Zhang X, Kirschning C, et al. Toll-like receptor 7 activation enhances CD8+ T cell effector functions by promoting cellular glycolysis. Front Immunol. 2019;10:2191.","journal-title":"Front Immunol"},{"issue":"5","key":"2560_CR66","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.immuni.2019.09.003","volume":"51","author":"EH Ma","year":"2019","unstructured":"Ma EH, Verway MJ, Johnson RM, Roy DG, Steadman M, Hayes S, et al. Metabolic profiling using stable isotope tracing reveals distinct patterns of glucose utilization by physiologically activated CD8(+) T cells. Immunity. 2019;51(5):856\u201370.","journal-title":"Immunity"},{"issue":"3","key":"2560_CR67","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41419-019-1494-4","volume":"10","author":"HS Yi","year":"2019","unstructured":"Yi HS, Kim SY, Kim JT, Lee YS, Moon JS, Kim M, et al. T-cell senescence contributes to abnormal glucose homeostasis in humans and mice. Cell Death Dis. 2019;10(3):249.","journal-title":"Cell Death Dis"},{"issue":"2","key":"2560_CR68","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1002\/stem.2234","volume":"34","author":"M Bottcher","year":"2016","unstructured":"Bottcher M, Hofmann AD, Bruns H, Haibach M, Loschinski R, Saul D, et al. Mesenchymal stromal cells disrupt mTOR-signaling and aerobic glycolysis during T-cell activation. Stem Cells. 2016;34(2):516\u201321.","journal-title":"Stem Cells"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-021-02560-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-021-02560-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-021-02560-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T10:15:40Z","timestamp":1631182540000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-021-02560-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,9]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2560"],"URL":"https:\/\/doi.org\/10.1186\/s13287-021-02560-x","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,9]]},"assertion":[{"value":"6 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal experiments in this study were conducted under ethical conditions approved by the Institutional Animal Care and Use Committee of The Third Affiliated Hospital of Sun Yat-sen University. Isolation and expansion of hWJ-MSCs were approved by the Institutional Human Ethics Committee of The Third Affiliated Hospital of Sun Yat-sen University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"496"}}